Table 4

Engraftment data for multilymphoid progenitor transplants assessed by FACS

Mouse IDVectorCIDDay post BMT% huCD45+ cells%CD34+Lin/huCD45+ cellsFold increase CD34+Lin human cells
Experiment A       
    1 F36V-MPL 49 46.7 13.8 154.7 
    2 F36V-MPL 49 19.9 20.8 114.1 
    3 F36V-MPL − 49 0.14 
    4 F36V-MPL − 49 
    5 F36V-MPL − 49 0.49 
    6 Control (no transplant)  49 
Experiment B       
    1 F36V-MPL 30.5 18.3 101 
    2 F36V-MPL 37 7.67 53.4 69 
    3 F36V-MPL − 0.23 31.2 0.4 
    4 F36V-MPL − 37 0.086 
    5 F36V-MPL − 37 0.38 
    6 Control (no transplant) − 37 
Summary    Mean % huCD45+ cells Mean %CD34+Lin/huCD45+ cells Mean fold increase CD34+Lin human cells 
 F36V-MPL  26.2 26.5 109.7 
 F36V-MPL −  0.15 5.2 0.06 
Mouse IDVectorCIDDay post BMT% huCD45+ cells%CD34+Lin/huCD45+ cellsFold increase CD34+Lin human cells
Experiment A       
    1 F36V-MPL 49 46.7 13.8 154.7 
    2 F36V-MPL 49 19.9 20.8 114.1 
    3 F36V-MPL − 49 0.14 
    4 F36V-MPL − 49 
    5 F36V-MPL − 49 0.49 
    6 Control (no transplant)  49 
Experiment B       
    1 F36V-MPL 30.5 18.3 101 
    2 F36V-MPL 37 7.67 53.4 69 
    3 F36V-MPL − 0.23 31.2 0.4 
    4 F36V-MPL − 37 0.086 
    5 F36V-MPL − 37 0.38 
    6 Control (no transplant) − 37 
Summary    Mean % huCD45+ cells Mean %CD34+Lin/huCD45+ cells Mean fold increase CD34+Lin human cells 
 F36V-MPL  26.2 26.5 109.7 
 F36V-MPL −  0.15 5.2 0.06 

Fold expansion of human CD34+Lin cells is derived from the percentage of huCD45+CD34+Lin cells and total cells harvested from bone marrow (femurs, tibias) at times shown divided by number of cells transplanted (n = 12 mice, 2 independent experiments), fold expansion of CD34+Lin cells is significantly greater in CID-treated mice (P = .006) compared with all other groups.

or Create an Account

Close Modal
Close Modal